Enliven Therapeutics appoints Kristine Ball to board ahead of planned phase 3 trial this year
ELVN•Enliven Therapeutics appointed Kristine Ball to its board of directors ahead of a planned phase 3 trial initiation this year.
1. Board appointment
Enliven Therapeutics appointed Kristine Ball to its board of directors ahead of a planned phase 3 trial initiation this year.
